Life Sciences

Regeneron and Bayer caught in Genentech’s VEGF Trap
In the UK leg of the litigation relating to the potential blockbuster drug Eylea, marketed by Regeneron Pharmaceuticals, Inc. and Bayer Healthcare, the High Court has handed down a judgement ruling that Eylea infringes a patent held by Genentech, Inc.
Read More
05
Apr
2012
An Important Day for Supplementary Protection Certificates
On Friday 10th February, the UK High Court had a busy morning applying recent decisions of the Court of Justice of the European Union (CJEU) in Medeva (C-322/10) and related referrals, to real world situations involving Supplementary Protection Certificates (SPCs).
Read More
23
Feb
2012
SPCs – Decisions rain down from the Court of Justice of the European Union (CJEU)
Between late November and mid-December, there was a flurry of activity at the CJEU, with a number of decisions being handed down that are relevant to Supplementary Protection Certificates (SPCs) - a unique form of intellectual property right that provides an additional monopoly that comes into force after expiry of a patent.
Read More
26
Jan
2012

Type

Service

Sector

Archive